Antimicrobial peptides: new drugs for bad bugs?

Antimicrobial peptides: new drugs for bad bugs?
复制标题

DOI:
10.1517/14712598.2013.844227
复制
发表时间:
2014-01
影响因子:
4.6
通讯作者:
Montelaro RC
Montelaro RC
中科院分区:
医学3区
文献类型:
--
作者:
Steckbeck JD;Deslouches B;Montelaro RC

文献摘要

参考文献

被引文献

相似文献

抗生素一直是最成功的治疗方法之一,并使现代医学的许多最伟大的进步成为可能。然而,抗药性细菌正在成为严重的公共卫生威胁,最近有报道称,细菌菌株对所有批准的抗生素都有抗药性。抗菌肽(AMP)是一种天然存在的分子,有可能成为一类针对这些难以治疗的细菌的新型抗感染药物的基础。讨论了AMPS的独特活动和特征,重点讨论了启动抗生素管道的临床重要性以及AMPS在未来对抗耐药细菌方面可以发挥的作用。
Antibiotics have been among the most successful classes of therapeutics and have enabled many of modern medicine’s greatest advances. However, antibiotic-resistant bacteria are emerging as critical public health threats, with recent accounts of bacterial strains resistant to all approved antibiotics. Antimicrobial peptides (AMPs) are naturally occurring molecules with the potential to serve as the basis for a new class of anti-infectives targeting these difficult-to-treat bacteria. The unique activities and features of AMPs are discussed, with a focus toward the clinical importance of priming the antibiotic pipeline and the role AMPs can fulfill in the future of fighting drug-resistant bacteria.
DOI: 10.1038/nature05233
发表时间: 2006-10-19
期刊: NATURE
影响因子: 64.8
作者:
Loose, Christopher;Jensen, Kyle;Stephanopoulos, Gregory
通讯作者: Stephanopoulos, Gregory
DOI: 10.1371/journal.ppat.1001067
发表时间: 2010-10-28
期刊: PLoS pathogens
影响因子: 6.7
作者:
Peters BM;Shirtliff ME;Jabra-Rizk MA
通讯作者: Jabra-Rizk MA
DOI: 10.1128/aac.00064-12
发表时间: 2012-05-01
影响因子: 4.9
作者:
de la Fuente-Nunez, Cesar;Korolik, Victoria;Hancock, Robert E. W.
通讯作者: Hancock, Robert E. W.
DOI: 10.1093/nar/gkn823
发表时间: 2009-01
影响因子: 14.9
作者:
Wang G;Li X;Wang Z
通讯作者: Wang Z
DOI: 10.1021/ja0107475
发表时间: 2001-08-08
影响因子: 15
作者:
Liu, DH;DeGrado, WF
通讯作者: DeGrado, WF